329 related articles for article (PubMed ID: 16169783)
1. Gene therapy with human osteoprotegerin decreases callus remodeling with limited effects on biomechanical properties.
Ulrich-Vinther M; Schwarz EM; Pedersen FS; Søballe K; Andreassen TT
Bone; 2005 Dec; 37(6):751-8. PubMed ID: 16169783
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength.
Ulrich-Vinther M; Andreassen TT
Calcif Tissue Int; 2005 Apr; 76(4):280-6. PubMed ID: 15812581
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice.
Kostenuik PJ; Bolon B; Morony S; Daris M; Geng Z; Carter C; Sheng J
Bone; 2004 Apr; 34(4):656-64. PubMed ID: 15050896
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
Ulrich-Vinther M
Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
[TBL] [Abstract][Full Text] [Related]
5. Strontium is incorporated into the fracture callus but does not influence the mechanical strength of healing rat fractures.
Brüel A; Olsen J; Birkedal H; Risager M; Andreassen TT; Raffalt AC; Andersen JE; Thomsen JS
Calcif Tissue Int; 2011 Feb; 88(2):142-52. PubMed ID: 21153023
[TBL] [Abstract][Full Text] [Related]
6. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.
Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM
J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271
[TBL] [Abstract][Full Text] [Related]
7. Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing.
Flick LM; Weaver JM; Ulrich-Vinther M; Abuzzahab F; Zhang X; Dougall WC; Anderson D; O'Keefe RJ; Schwarz EM
J Orthop Res; 2003 Jul; 21(4):676-84. PubMed ID: 12798068
[TBL] [Abstract][Full Text] [Related]
8. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
[TBL] [Abstract][Full Text] [Related]
9. Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading.
Ichinose Y; Tanaka H; Inoue M; Mochizuki S; Tsuda E; Seino Y
Calcif Tissue Int; 2004 Oct; 75(4):338-43. PubMed ID: 15549649
[TBL] [Abstract][Full Text] [Related]
10. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
11. Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss.
Zehnder AF; Kristiansen AG; Adams JC; Kujawa SG; Merchant SN; McKenna MJ
Laryngoscope; 2006 Feb; 116(2):201-6. PubMed ID: 16467704
[TBL] [Abstract][Full Text] [Related]
12. 1Alpha,25-dihydroxy-2beta(3-hydroxypropoxy)vitamin D3 (ED-71) suppressed callus remodeling but did not interfere with fracture healing in rat femora.
Cao Y; Mori S; Mashiba T; Kaji Y; Manabe T; Iwata K; Miyamoto K; Komatsubara S; Yamamoto T
Bone; 2007 Jan; 40(1):132-9. PubMed ID: 16962400
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model.
Yang SY; Mayton L; Wu B; Goater JJ; Schwarz EM; Wooley PH
Arthritis Rheum; 2002 Sep; 46(9):2514-23. PubMed ID: 12355500
[TBL] [Abstract][Full Text] [Related]
14. Obesity does not affect the healing of femur fractures in mice.
Histing T; Andonyan A; Klein M; Scheuer C; Stenger D; Holstein JH; Veith NT; Pohlemann T; Menger MD
Injury; 2016 Jul; 47(7):1435-44. PubMed ID: 27156834
[TBL] [Abstract][Full Text] [Related]
15. Low-magnitude high-frequency vibration enhances gene expression related to callus formation, mineralization and remodeling during osteoporotic fracture healing in rats.
Chung SL; Leung KS; Cheung WH
J Orthop Res; 2014 Dec; 32(12):1572-9. PubMed ID: 25131218
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture.
Nakamura T; Hara Y; Tagawa M; Tamura M; Yuge T; Fukuda H; Nigi H
J Bone Miner Res; 1998 Jun; 13(6):942-9. PubMed ID: 9626625
[TBL] [Abstract][Full Text] [Related]
17. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep.
Egermann M; Baltzer AW; Adamaszek S; Evans C; Robbins P; Schneider E; Lill CA
Hum Gene Ther; 2006 May; 17(5):507-17. PubMed ID: 16716108
[TBL] [Abstract][Full Text] [Related]
18. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.
Yasuda H; Shima N; Nakagawa N; Mochizuki SI; Yano K; Fujise N; Sato Y; Goto M; Yamaguchi K; Kuriyama M; Kanno T; Murakami A; Tsuda E; Morinaga T; Higashio K
Endocrinology; 1998 Mar; 139(3):1329-37. PubMed ID: 9492069
[TBL] [Abstract][Full Text] [Related]
19. The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism.
Padagas J; Colloton M; Shalhoub V; Kostenuik P; Morony S; Munyakazi L; Guo M; Gianneschi D; Shatzen E; Geng Z; Tan HL; Dunstan C; Lacey D; Martin D
Calcif Tissue Int; 2006 Jan; 78(1):35-44. PubMed ID: 16362459
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis.
Bolon B; Carter C; Daris M; Morony S; Capparelli C; Hsieh A; Mao M; Kostenuik P; Dunstan CR; Lacey DL; Sheng JZ
Mol Ther; 2001 Feb; 3(2):197-205. PubMed ID: 11237676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
